Kala Pharmaceuticals Announces Up to $31 Million Private

Nov 28, 2022  · Kala Pharmaceuticals Announces Up to $31 Million Private Placement Financing November 28, 2022 16:01 ET | Source: Kala Pharmaceuticals, Inc. Kala Pharmaceuticals, Inc.


Install CouponFollow Chrome Extension   CouponFollow Extension

$31
OFF

Kala Pharmaceuticals Announces Up To $31 Million Private

1 week from now

Nov 28, 2022  · Kala Pharmaceuticals Announces Up to $31 Million Private Placement Financing November 28, 2022 16:01 ET | Source: Kala Pharmaceuticals, Inc. Kala Pharmaceuticals, Inc.

globenewswire.com

$31
OFF

Kala Pharmaceuticals Enters Into Private Placement Financing For …

1 week from now

Nov 28, 2022  · Prostock-Studio. Kala Pharmaceuticals (NASDAQ:KALA) on Monday saidit had entered into a private placement financing for proceeds of up to $31M. KALA will sell shares of …

seekingalpha.com

$12500000
OFF

KALA BIO Announces $12,500,000 Private Placement - Yahoo …

1 week from now

Jun 27, 2024  · In the private placement, KALA has agreed to sell 1,197,314 shares of its common stock at a price of $5.85 per share and 9,393 shares of its Series H Preferred Stock at a price …

yahoo.com

$31
OFF

Kala Pharmaceuticals Announces Up To $31 Million Private …

1 week from now

ARLINGTON, Mass., Nov. 28, 2022 (GLOBE NEWSWIRE) -- Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, …

benzinga.com

$31
OFF

Kala Pharmaceuticals Launches $31 Million Private Placement

1 week from now

-- Kala Pharmaceuticals said Monday it has struck a deal to sell up to $31 million shares and series E convertible non-redeemable preferred stock to a life sciences-focused investor. The...

marketscreener.com

$31
OFF

Kala Pharmaceuticals Announces Up To $31 Million Private …

1 week from now

KALA Kala Pharmaceuticals Inc Kala Pharmaceuticals Announces Up to $31 Million Private Placement Financing. ARLINGTON, Mass., Nov. 28, 2022 (GLOBE NEWSWIRE) -- Kala …

advfn.com

$31
OFF

Kala Pharmaceuticals Announces Up To $31 Million Private …

1 week from now

Nov 28, 2022  · Kala intends to use proceeds from the financing to advance the clinical development of KPI-012 for the treatment of PCED, as well as for general corporate purposes.

yahoo.com

$31
OFF

Kala Pharmaceuticals Announces Up To $31M Private Placement …

1 week from now

ARLINGTON, Mass., Nov. 28, 2022 (GLOBE NEWSWIRE) — Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, …

citybiz.co

$31
OFF

Kala Pharmaceuticals Announces Up To $31 Million Private …

1 week from now

Nov 28, 2022  · Read Press Release for Kala Pharmaceuticals (KALA) published on Nov. 28, 2022 - Kala Pharmaceuticals Announces Up to $31 Million Private Placement Financing Stocks …

marketchameleon.com

$31
OFF

Kala Pharmaceuticals Announces Up To $31 Million Private …

1 week from now

Nov 28, 2022  · Kala Pharmaceuticals, Inc. announced that it has entered into a definitive agreement with a life sciences-focused investor for the sale, in a private placement priced at …

biospace.com

$31
OFF

KALA BIO, Inc. (KALA) Latest Stock News - Seeking Alpha

1 week from now

4 days ago  · Kala Pharmaceuticals enters into private placement financing for up to $31M SA News Mon, Nov. 28, 2022. ... Kala Pharmaceuticals GAAP EPS of -$0.45 misses by $0.11, …

seekingalpha.com

$31
OFF

Kala Pharmaceuticals Announces Up To $31 Million Private …

1 week from now

ARLINGTON, Mass., Nov. 28, 2022 (GLOBE NEWSWIRE) -- Kala Pharmaceuticals, Inc. (KALA), a clinical-stage biopharmaceutical company dedicated to the research, 🚀 Enjoy a 7-Day Free …

gurufocus.com

$31
OFF

Kala Pharmaceuticals Announces Up To $31 Million Private …

1 week from now

ARLINGTON, Mass., Nov. 28, 2022 -- Kala Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of …

marketscreener.com

$31
OFF

Kala Pharmaceuticals Announces Up To $31 Million Private …

1 week from now

Nov 28, 2022  · Kala Pharmaceuticals, Inc. (NASDAQ:KALA) has entered into a definitive agreement for a private placement to raise up to $31 million. The first tranche includes the sale …

stocktitan.net

20%
OFF

Kala Pharmaceuticals Shares Jump Nearly 20% On News Of IND, …

1 week from now

By Stephen Nakrosis Shares of Kala Pharmaceuticals Inc. were trading higher after-hours Monday, after the company said it entered into a definitive agreement for private-placement …

advfn.com

00%
OFF

KalVista Pharmaceuticals Enters Into Non-Dilutive Synthetic …

1 week from now

Under the terms of the synthetic royalty financing agreement, KalVista will immediately receive $100 million and be obligated to pay DRI a tiered royalty of 5.00% of annual global net sales …

kalvista.com

FAQs about Kala Pharmaceuticals Announces Up to $31 Million Private Coupon?

How much did Kala sell in a private placement?

The private placement was led by SR One with participation from ADAR1 Capital Management and another life sciences-focused investor. In the private placement, KALA has agreed to sell 1,197,314 shares of its common stock at a price of $5.85 per share and 9,393 shares of its Series H Preferred Stock at a price of $585.00 per share. ...

How much does Kala's private placement cost?

In the private placement, KALA has agreed to sell 1,197,314 shares of its common stock at a price of $5.85 per share and 9,393 shares of its Series H Preferred Stock at a price of $585.00 per share. The private placement is expected to close on or about June 28, 2024, subject to the satisfaction of customary closing conditions. ...

How much will Kala sell?

Under the terms of the agreement, Kala has agreed to sell in a first tranche an aggregate of 76,813 shares of its common stock at a price of $5.75 per share and an aggregate of 9,666 shares of its Series E Preferred at a price of $575.00 per share, for gross proceeds of approximately $6 million. ...

Does Kala bio offer non-statutory stock options?

ARLINGTON, Mass., Jan. 19, 2024 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (Nasdaq:KALA), today announced that the Company granted non-statutory stock options to a new employee as an inducement award outside ... ...

Did Kala give a new employee non-statutory stock options?

ARLINGTON, Mass., July 19, 2023 (GLOBE NEWSWIRE) -- Kala Pharmaceuticals, Inc. (Nasdaq:KALA), today announced that the Company granted non-statutory stock options to a new employee as an inducement aw... ...

Is Kala launching a Phase 2b clinical trial in PCED patients?

Kala intends to initiate a Phase 2b clinical trial evaluating the efficacy and safety of two doses of KPI-012 in PCED patients with a broad range of underlying etiologies in the fourth quarter of 2022. ...

Install CouponFollow Extension on Chrome

Install the CouponFollow extension to search for discount codes when shopping the fastest!

Install CouponFollow Chrome Extension   Install CouponFollow Chrome Extension